Generic medicines may cost higher in the US if Indian pharma companies decide to pass on the 26 per cent tariff in their ...

LBB Specialties, a leader in specialty chemicals and ingredient distribution in North America , is pleased to announce a new ...

Large Indian drug manufacturers experienced relief as President Trump's administration decided against imposing expected ...

New Delhi: In line with the wholesale price index (WPI) at 1.74028% for the year 2024 over 2023, through a recent notification, the drug price regulator, National Pharmaceutical Pricing Authority ...

SCIENTURE HOLDINGS, INC. (NASDAQ: SCNX) a holding company for existing and planned pharmaceutical operating companies focused on providing enhanced value to patients, physicians and caregivers through ...

Through this collaboration, LBB Specialties will become Kerry's preferred distribution partner in the United States, expanding access to high-quality pharmaceutical lactose ingredients. Kerry's ...

The "Regulatory Compliance for Dietary Supplements in the US, EU and Canada" training has been added to ResearchAndMarkets.com's offering. A nutraceutical product with quality as good as a ...

One of the great things about equity markets is that you don't need a fortune to get started. Though strong companies that ...

“This agreement is a long-term investment into securing the future of botanical drug innovation,” said Uttam Patil, Ph.D., Chief Executive Officer of ABVC. “By locking in upstream resources in Asia, ...

Fette Compacting is on a successful path and presents itself confidently as a strategic partner for the pharmaceutical and ...

Tasman Therapeutics, Inc. (Tasman) has announced plans to raise $175 million in Series A funding to support the late-stage clinical development and eventual commercialization of R-107. This innovative ...

The COVID-19 pandemic sparked conversations about the pharmaceutical industry and the future of drug development. How can pharma quickly meet the needs of patients during a pandemic, and what does ...